Welcome!
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.
Dr. Jack West recently had the privilege to spend time with Drs. Millie Das and Matthew Gubens for a series of case-based discussions regarding...
Dr. Jack West recently had the privilege to spend time with Drs. Millie Das and Matthew Gubens for a series of case-based discussions regarding...
Dr. Jack West recently had the privilege to spend time with Drs. Millie Das and Matthew Gubens for a series of case-based discussions regarding...
Dr. Jack West recently had the privilege to spend time with Drs. Millie Das and Matthew Gubens for a series of case-based discussions regarding...
Dr. Jack West recently had the privilege to spend time with Drs. Millie Das and Matthew Gubens for a series of case-based discussions regarding...
We couldn't do what we do without you, our volunteers! From sharing their own philanthropic efforts, sitting on the GRACE board, helping at the ASCO...
Join us as we continue to grow and help others ~ There are very few opportunities to help cancer patients or their loved ones and caretakers learn...
GRACE is pleased to have again partnered with Patient Resource Publishing to bring you the fourth addition of Cancer Survivorship. This helpful, free...
I was dx'd with Bronchioavelor Carcinomna (BAC) in Sept 2011. I tested postive for EGFR and was placed on Tarceva and I have been on it for almost ten...
Dear Doctors, could you please help me with the right treatment for newly detected mutation by blood biopsy. This is MET , exon 16, H1112R mutation in combination with my existing one which is exon 21, l858r. It has been reported that those two mutations exist in equal amounts.
Our friend and partner, Narjust (N.J.) Duma, MD is a Chief Hematology/Medical Oncology Fellow at Mayo Clinic in Rochester, MN. Dr. Duma is committed to her research and advocacy in diversity and inclusion. She was recognized as the 2018 resident of the year by the National Hispanic Medical Association.
N.J. speaks to cancer myths in the Latino community, and in this video N.J. discusses 3 common myths about breast cancer. Stay tuned for more great videos!
Our friend and partner, Narjust (N.J.) Duma, MD is a Chief Hematology/Medical Oncology Fellow at Mayo Clinic in Rochester, MN. Dr. Duma is committed to her research and advocacy in diversity and inclusion. She was recognized as the 2018 resident of the year by the National Hispanic Medical Association.
Is there any update on efficacy of osicent versus tagrix please? Cost is a issue and wanted to know if one is more effective than the other as erlotinib isnt working and lung cancer has widespread brain metastatis.any info will be valuable please.
My mom has been on her second line treatment, Tagrisso, for over a year. Recently we got a PET/CT scan and a MRI. The PET/CT showed mostly stable disease but two lymph nodes and a bone spot that are showing activity again. The MRI (brain scan) showed 3 suspicious lesions which will be radiated with cyberkife. The problem is, the MRI also showed early signs of leptomeningeal disease (LMD). Obviously this is a very serious situation. Since my mom already had whole brain radiation two years ago, it is not an option. Cyberknife is also not an option for LMD either.
Hello,
I have NSCLC EFGR exon 19 deletion and had 2 VATS, Tarceva and have been on Tagrisso for over 20 months. I have been on a two week break because of suspected interstial lung disease. My breathing has improved but I won't have another CT for 2 more weeks. My oncologist has not prescribed steroids or antibiotics and said he is very unsure of how to proceed. I understand that this complication is reasonable rare (less than 4%) but that it can be fatal. I am looking for input or resources on how to proceed immediately with the pneumonitis (other than stopping the T
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.